LITS Lite Strategy, Inc.
USFinancial ServicesAs of 2026-07-10 16:00
Why LITS matters now
Lite Strategy, Inc. (LITS) is a US stock in Financial Services. The latest InvestLog snapshot shows $1.01 with +1.71% on the session and $34.4M in market capitalization; recent performance reads 1-month -24.06% and YTD -37.29%.
The latest financial table shown here is Q3 2026, with revenue of $0.00, net income of $-23.7M, and EPS of $-3.56. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -37.0%.
The latest indexable market news headline is "Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam" from GlobeNewsWire.
Additional event context on this page matters because recent insider activity includes File Justin J. filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.10
P/S
0.00
EV/EBITDA
-1.70
DCF Value
$2.68
FCF Yield
-37.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-90.8%
ROA
-105.2%
ROIC
-22.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $0.00 | $-23.7M | $-3.56 |
| Q2 2026 | $0.00 | $-30.8M | $-4.62 |
| Q1 2026 | $0.00 | $-3.6M | $-0.55 |
| Q4 2025 | $0.00 | $-2.7M | $-0.40 |
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Financial Services
Industry
Asset Management - Cryptocurrency
Country
US
Exchange
—
Beta
0.04
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.